About Pharma Industry

BNET Pharma provides daily industry trends and news coverage with insights for managers and executives about major manufacturers of pharmaceuticals and medicine. In addition to detailed drug company profiles, we bring you industry analysis on new partnerships, drug patents and products, cost management, investments, pharmaceutical related lawsuits, and a host of other important business issues.

Claim: LeCarre's "The Constant Gardener" Was Based on Pfizer Trovan Case

By Jim Edwards | Feb 17, 2009

The Connecticut Law Tribune claims that The Constant Gardener, a John Le Carré book and later a movie with the same name, is in fact based on the Pfizer Trovan case. But is the claim true? A look at the timeline of both the case and the book suggest it is possible … as long as Le Carré is a very fast writer.

While many have drawn parallels between the two — the movie and the lawsuit both posit an unscrupulous drug company doing fatal drug testing on African children and then trying to cover it up — this is the first report to BNET’s knowledge that directly asserts that The Constant Gardner is essentially a rewrite of Pfizer’s ill-fated meningitis drug tests in Nigeria. The story provides no sourcing for its claim, just a bald assertion. The Conn. Law Trib.:

West Haven, Conn., attorney Richard Altschuler has reams of paper and endless boxes of notes that tell the story. Medical experiments on children. Claims that a large American pharmaceutical company exploited a third world country.

Sounds like the plot of a novel? It was. The book is called “The Constant Gardener.” A movie of the same name followed in 2005.

But the thing is, both were based on reality, on a case that Altschuler has been fighting for eight years against Pfizer Inc.

Altschuler won an important ruling in February allowing 88 Nigerian families to pursue their claims against Pfizer in US courts. (Back story: In 1996, during a meningitis outbreak in Nigeria, Pfizer tested a drug, Trovan, on children there. About 11 kids died. The Washington Post: “Trovan was never approved for use by American children. The Food and Drug Administration approved it for adults in 1998 but later severely restricted its use after reports of liver failure. The European Union banned the drug in 1999.”)

While the Constant Gardener has often been discussed in the same breath as Trovan, Le Carré has previously denied that his book and the case draw from the same source. Big Pharma’s enfant terrible, Marcia Angell, reviewed the tome in the NY Review of Books and said this:

… in the real world, we don’t hear of pharmaceutical whistle-blowers being murdered, and there have been several whistle-blowers recently.

But le Carré himself cautions us against drawing any such conclusions. In an author’s note at the end of the book he makes a grudging disclaimer to the effect that no person or organization in the book is based on an actual person or organization. He also makes it clear, however, that he is obliged to say this “in these dog days when lawyers rule the universe.” He adds, “But I can tell you this. As my journey through the pharmaceutical jungle progressed, I came to realize that, by comparison with reality, my story was as tame as a holiday postcard.”

During the making of the movie, a copy of a documentary, “Dying for Drugs,” that was made for the UK’s Channel 4 in 2003, was given to the Constant Gardener cast. The documentary was about the Trovan case:

Director [of "Dying for Drugs"] Brian Woods met John Le Carré and Fernando Mereilles during production of “The Constant Gardener” in 2005, and copies of the film were distributed to members of the cast.

This all suggests that Le Carré’s book, the movie, and the Trovan case were on parallel tracks for some time. However, Le Carré ’s book was published in 2001, two years before the Channel 4 documentary. The obvious question here is, did Le Carré read about the case between 1996 and the time he finished writing?

He could have, but the timeline is a tight squeeze. Trovan’s Nigerian trials first made headlines in the Western press in 2000, when the Washington Post published a December investigation of the Nigerian trials. Here’s the text of a Pfizer press release from the time, which, unfortunately, is the only evidence I could gather that isn’t behind a pay wall. In both Lexis-Nexis and Factiva, the WaPo story on Trovan is the first mention in the media of a controversy in Nigeria.

In order for Le Carré to have based his book on the Trovan case, he would either have had to have inside knowledge of what was going on in Nigeria at the time (not implausible for a man of Le Carre’s social standing and background as an MI5 employee), or he would have had to read the Washington Post article and then bash out his novel very quickly. Or both.

Jim Edwards, a former managing editor of Adweek, has covered drug marketing at Brandweek for four years, and is a former Knight-Bagehot fellow at Columbia University's business and journalism schools. Follow him on Twitter or send him an email.

BNET User Analysis

Web Buzz:
  • Thom Yorke Dissing The Album Format Doesn't Mean 'Free' Business Models Don't Work

    TechDirt - 101 days 1 hour 20 minutes ago

    I believe that one of our frequent critics has been submitting a series of stories which s/he believes "disproves" the basics of what we talk about here. I don't know for sure that it's the same individual, as they always use different names, but the names are all of the same nature, and the comments are effectively the same mocking tone --...

  • Pfizer's Trovan Settlement Demands Irk Nigerian Kleptocrats

    BNET Pharma - 187 days 18 hours 23 minutes ago

    Pfizer is emerging as an unexpected champion of the poor against Nigeria’s kleptocracy as it negotiates a $75 million settlement in the Trovan case. Back story: The case stems from tests Pfizer did in 1996 during a meningitis outbreak in the African nation. Eleven children died. Trovans use was restricted in the U.S. and banned in...

  • Pfizer Close to Settling Trovan Case in Nigeria

    BNET Pharma - 260 days 19 hours 47 minutes ago

    Pfizer is close to settling the Trovan litigation in Nigeria, and may have whittled the plaintiffs down to as little as $75 million. The case stems from tests Pfizer did in 1996 during a meningitis outbreak in the African nation. Eleven children died. Trovan's use was restricted in the U.S. and banned in Europe. The events may have inspired the...

  • Pfizer settles Nigerian Trovan trial case out of court

    In-Pharma Technologist - 230 days 3 hours 8 minutes ago

    Prosecutors in the northern Nigerian state of Kano had been seeking $2.75bn (€2bn) in compensation from the US drug giant, accusing it of conducting an unlicensed trial of the drug in 200 children during a meningitis epidemic in 1996. While details of the settlement are not due to be released until May 25, various media reports suggest Pfizer...

  • Pfizer's Flip-Flop on the Trovan Settlement

    BNET Pharma - 228 days 17 hours 54 minutes ago

    Pfizer is close to settling the Trovan case for $75 million, the Washington Post reported Saturday. BNET readers learned of this development on March 6. (Back story here.) Back then, Pfizer spokesperson waved BNET off the story, saying news of a settlement was "not accurate" because talks were ongoing. A month later, the WP reports an identical...

 
Reply to Story

BNET TalkbackShare your ideas and expertise on this topic

Subscribe to this discussion via Email or RSS

  •  
    1

    Kunle Ishola

    06/05/09 | Report as spam

    RE: Claim: LeCarre's

    I reckon Le Clarre's book and film might share plausible similarities with the Trovan trial in Nigeria but my manuscript on Pfizer's human guinea pig experiment in Kano in 1996 is a very deep legal and factual narration of this misadventure as a counsel on record for the victims of the trial in Nigeria.
    Kunle Ishola, Esq.
    +23418033752607
    kunleish@yahoo.com

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
Click Here
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here